. . . . . . . . . . . . . . . . . . . . . . "a(CHEBI:lipopolysaccharide) -> cat(p(HGNC:MMP9))" . "cat(p(HGNC:TLR4)) -> (a(CHEBI:lipopolysaccharide) -> cat(p(HGNC:MMP9)))" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "20131211" . "The specificity of the action of the two antibodies was first determined using known TLR-2 and TLR-4 agonists (PG and LPS)...In Fig. 5A, LPS treatment caused an increase in MMP-9 activity by zymography. This enhancement ...but was markedly reduced by the anti-TLR-4 antibody" . . "Selventa" . . . . "2014-07-03T14:32:04.164+02:00"^^ . . .